Assay
PGDB_AS001457
System: cell_basedCell line: NCI-H1155
Assay context summary
Assay context
Activity compounds and values
Activity records
| Structure | Metric | Control | Relation | Value | Unit | Concentration | Time | Target | E3 | Cell line | Patent | Record ID | Compound | Assay | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % Cell viability | - | = | 26 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A016095 | PGDB_C001300 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 25 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A021937 | PGDB_C001295 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 5 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A031974 | PGDB_C001293 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 5 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A037388 | PGDB_C001291 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 4 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A048587 | PGDB_C001296 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 26 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A062962 | PGDB_C001298 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 23 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A065132 | PGDB_C001299 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 24 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A069502 | PGDB_C001297 | PGDB_AS001457 | View | |
| % Cell viability | - | = | 23 | % | 500 nM | 72 h | - | - | NCI-H1155 | EP4617270A1 | PGDB_A075262 | PGDB_C001294 | PGDB_AS001457 | View |